enalaprilat ( mk-422 ) , an intravenously administered angiotensin-converting enzyme inhibitor , which is the parent compound of the oral angiotensin-converting enzyme inhibitor enalapril ( mk-421 ) , was studied in 11 patients with asymptomatic accelerated hypertension .
C0014027
enalaprilat
C0020540
accelerated hypertension